NCT02475148View on ClinicalTrials.gov

A Study to Investigate Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of JNJ-54175446 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Healthy
Interventions
DRUG

JNJ 54175446

DRUG

Placebo

OTHER

High fat/high Calorie Breakfast

Trial Locations (1)

Unknown

Merksem

Sponsors
All Listed Sponsors
lead

Janssen-Cilag International NV

INDUSTRY